Abstract PR09: KRAS-targeted PROTAC degraders are broadly efficacious against KRAS-dependent tumor models von Smith, Kathryn, Lopez-Arroyo, Andrea, Berk, Jason, Hegan, Peter, Nower, Peter, Tice, Samantha, Moutran, Aurelie, Pizzano, Jennifer, Dowtin, Amanda, Bookbinder, Mark, Bortolon, Elizabeth, Cadelina, Greg, Karim, Fazlul, Digianantonio, Katie, Bekes, Miklos, Medina, Jesus

Volltext